β-blockers in Heart Failure
Sustained release metoprolol succinate was studied in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). All-cause mortality (primary endpoint) was significantly reduced with the extended-release formulation of metoprolol succinate (target dose 200 mg once daily) compared to placebo; mortality was reported in 7.3% of patients randomized to metoprolol ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- treatment of anemia in patients with heart disease
- β blockers in heart failure
- congestive heart failure ruggles service corporation
- drugs for heart failure josh corwin
- 29 1 identify the etiology pathophysiology and clinical
- patient assessment american heart association
- congestive heart failure kaleida health
- executive summary uk
- shetland sheepdogs are a relatively healthy breed but as
- chronic congestive heart failure information for wellcare
Related searches
- heart failure in cats
- heart failure in cats signs
- congestive heart failure in cats
- congestive heart failure in dogs final stages
- congestive heart failure in cats prognosis
- congestive heart failure in cats end stage
- signs of congestive heart failure in cats
- symptoms of congestive heart failure in dogs
- signs of heart failure in dogs
- heart failure in cats treatment
- symptoms of heart failure in women
- congestive heart failure in dogs painful